Martingale Asset Management’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-73,980
Closed -$762K 839
2024
Q4
$762K Sell
73,980
-380
-0.5% -$3.67K 0.02% 538
2024
Q3
$706K Buy
74,360
+15,424
+26% +$133K 0.02% 548
2024
Q2
$502K Buy
+58,936
New +$539K 0.01% 595

Other funds holding ENFN

Martingale Asset Management's ENFN Position: Q1 2025 in Review

Martingale Asset Management sold out of Enfusion, Inc. (ENFN) in Q1 2025, closing a stake of 73,980 shares — an estimated $762K sold.

Martingale Asset Management first reported a position in ENFN in Q2 2024 and held it in 3 quarters. The position peaked at $762K in Q4 2024. 132 funds tracked by Wall St. Rank hold ENFN as of Q1 2025.

  • Martingale Asset Management reported no remaining Enfusion, Inc. position as of Q1 2025 after selling out during the quarter.
  • Martingale Asset Management sold 73,980 Enfusion, Inc. shares in Q1 2025, an estimated $762K.
  • Martingale Asset Management first reported a position in Enfusion, Inc. in Q2 2024 and held it in 3 quarters.
  • Martingale Asset Management's Enfusion, Inc. position peaked at $762K in Q4 2024.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2025.

Based on Martingale Asset Management's 13F filing for Q1 2025, filed 14 May 2025.